MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Market Cap 2011-2026 | EW
As of April 16, 2026 Edwards Lifesciences Corporation has a market cap of $ 45.5 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.8 B | 42.5 B | 53 B | 47.8 B | 70 B | 51.7 B | 48.7 B | 35.3 B | 26.7 B | 20.5 B | 16.9 B | 13.3 B | 7.31 B | 10.3 B | 8.97 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70 B | 7.31 B | 33.5 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bruker Corporation
BRKR
|
6.9 K | $ 39.25 | -0.58 % | $ 5.85 K |  USA |
 |
Align Technology
ALGN
|
13.9 B | $ 185.94 | -0.32 % | $ 13.9 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.5 | -1.23 % | $ 1.69 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.61 | 2.33 % | $ 38 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.61 | 2.56 % | $ 135 M |  France |
 |
LENSAR
LNSR
|
71.3 M | $ 5.88 | -5.92 % | $ 70.3 M | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 63.77 | -1.3 % | $ 94.4 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 10.64 | 1.72 % | $ 301 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
175 M | $ 25.35 | -1.4 % | $ 214 M | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 2.69 | -1.82 % | $ 7.46 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
Stryker Corporation
SYK
|
147 B | $ 337.01 | -1.24 % | $ 129 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 16.96 | -4.99 % | $ 398 M | USA |
 |
Globus Medical
GMED
|
12.5 B | $ 93.16 | -1.47 % | $ 12.6 B | USA |
 |
Tactile Systems Technology
TCMD
|
640 M | $ 25.05 | -1.18 % | $ 573 M | USA |
 |
TELA Bio
TELA
|
32.4 M | $ 0.65 | -0.61 % | $ 30.5 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.96 | 1.03 % | $ 1.19 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 5.45 | 12.14 % | $ 1.15 B | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Tandem Diabetes Care
TNDM
|
1.26 B | $ 20.25 | -1.98 % | $ 1.38 B | USA |
 |
Inogen
INGN
|
160 M | $ 6.33 | 2.1 % | $ 168 M | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 1.03 | -0.93 % | $ 17.4 M | USA |
 |
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.85 | -1.27 % | $ 389 M | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 56.71 | 0.11 % | $ 1.67 B | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 38.23 | -3.07 % | $ 1.19 B | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 64.7 | -0.68 % | $ 3.53 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 88.42 | 0.55 % | $ 3.07 B | USA |